The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Open accessPublished version of a preprint
Abstract
We previously piloted the concept of a Connectivity Map (CMap), whereby genes, drugs, and disease states are connected by virtue of common gene-expression signatures. Here, we report more than a 1,000-fold scale-up of the CMap as part of the NIH LINCS Consortium, made possible by a new, low-cost, high-throughput reduced representation expression profiling method that we term L1000. We show that L1000 is highly reproducible, comparable to RNA sequencing, and suitable for computational inference of the expression levels of 81% of non-measured transcripts. We further show that the expanded CMap can be used to discover mechanism of action of small molecules, functionally annotate genetic variants of disease genes, and inform clinical trials. The 1.3 million L1000 profiles described here, as well as tools for their analysis, are available at https://clue.io.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The magnitude of gene expression changes has been reported to correlate with functional impact (Wawer et al. 2014; Subramanian et al. 2017)”
From Murine single-cell RNA-seq reveals cell-identity- and tissue-specific trajectories of aging (2019) · cites this paper as Subramanian et al. 2017
Experimental — accuracy not yet measuredIn the citing paper
“many transcriptional states could be faithfully inferred from a subset of gene expression measurements32,33”
From Combinatorial single-cell CRISPR screens by direct guide RNA capture and targeted sequencing (2020) · cites this paper as [33]
In the citing paper
“Alternatively, gene panels such as the L1000 panel34 could be used (Extended Data Figure 3), which has been shown to capture the majority of information contained in the full transcriptome across a wide range of perturbations34.”
From Targeted Perturb-seq enables genome-scale genetic screens in single cells (2020) · cites this paper as [34]
In the citing paper
“Perturbation modelling is underpinned by systematic databases of biological response to treatment (e.g. Connectivity Map [2], L1000, DRUG-seq [3]) and leverages the significant potential of machine learning (ML) to make predictive models, e.g., molecular targets or IC50 values.”
From A mini-review on perturbation modelling across single-cell omic modalities (2024) · cites this paper as [2]
In the citing paper
“Of note, the LINCS consortium, and in particular the L1000 Connectivity Map resource, provides a catalog of postperturbation transcriptomics profiles for thousands of compounds, offering a global map of the phenotypic response landscape of the medicinal chemistry space.205”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [205]
In the citing paper
“Another caveat of our approach is the likely existence of null signatures corresponding to innocuous molecules with no actual bioactivity in a given CC data type38.”
From Bioactivity descriptors for uncharacterized chemical compounds (2021) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Self-citation(2008) · Journal of Machine Learning Research · Cited by 33,051
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Open Babel: An open chemical toolbox
O'Boyle, N. M., Banck, M. S., James, C. A. J., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011) · Journal of Cheminformatics · doi:10.1186/1758-2946-3-33 · Cited by 10,745
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
<tt>BLAT</tt> —The <tt>BLAST</tt> -Like Alignment Tool
Kent, W. J. (2002) · Genome Research · doi:10.1101/gr.229202 · Cited by 8,480
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Self-citationThe Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
The GTEx Consortium, Ardlie, K. G., Deluca, D. S., Segrè, A. V., Sullivan, T. J., Young, T. R., Gelfand, E. T., Trowbridge, C. A., Maller, J. B., Tukiainen, T., et al. (2015) · Science · doi:10.1126/science.1262110 · Cited by 5,062
Self-citationDefining a Cancer Dependency Map
Tsherniak, A., Vazquez, F., Montgomery, P. G., Weir, B. A., Kryukov, G., Cowley, G. S., Gill, S., Harrington, W. F., Pantel, S., Krill-Burger, J. M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.010 · Cited by 3,276
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Illumina Inc. (2007). BeadStudio Normalization Algorithms for Gene Expression Data (Illumina Technical Bulletin Pub. No.470-2007-005).
Cited by
Sorted by citations
Items 901–1,000 of 1,010
Wang, B., Gong, S., Shao, W., Han, L., Li, Z., Zhang, Z., Zheng, Y., Ouyang, F., Ma, Y., Xu, W., et al. (2021) · Bioengineered · doi:10.1080/21655979.2021.1972081 · Cited by 21
Lee, G. H., Lekwuttikarn, R., Tafoya, E., Martin, M., Sarin, K. Y., & Teng, J. M. C. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.07.170 · Cited by 22
Jung, H. D., Sung, Y. J., & Kim, H. U. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.742902 · Cited by 22
Rivera, A. D., Pieropan, F., Williams, G. H., Calzolari, F., Butt, A. M., & Azim, K. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112436 · Cited by 22
Liang, D., Yu, C., Ma, Z., Yang, X., Li, Z., Dong, X., Qin, X., Du, L., & Li, M. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.12.005 · Cited by 21
AI-powered drug repurposing for developing COVID-19 treatments
Liu, Z., Chen, X., Carter, W., Moruf, A., Komatsu, T. E., Pahwa, S., Chan‐Tack, K. M., Snyder, K., Petrick, N., Cha, K., et al. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824010-6.00005-8 · Cited by 26
Self-citationYuan, M., Shong, K. E., Li, X., Ashraf, S., Shi, M., Kim, W., Nielsen, J., Türkez, H., Shoaie, S., Uhlén, M., et al. (2022) · Cancers · doi:10.3390/cancers14061573 · Cited by 21
Integration of Omics and Phenotypic Data for Precision Medicine
Zhao, J., Feng, Q., & Wei, W. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2265-0_2 · Cited by 25
Bao, Z., Cheng, J., Zhu, J., Ji, S., Gu, K., Zhao, Y., Yu, S., & Meng, Y. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s354826 · Cited by 22
Zhao, S., Wu, Y., Wei, Y., Xu, X., & Zheng, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.876616 · Cited by 21
Multi-Omics Immune Interaction Networks in Lung Cancer Tumorigenesis, Proliferation, and Survival
Ye, Q., Hickey, J., Summers, K., Falatovich, B., Gencheva, M., Eubank, T. D., Ivanov, A. V., & Guo, N. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314978 · Cited by 20
Selvin, T., Berglund, M., Lenhammar, L., Jarvius, M., Nygren, P., Fryknäs, M., Larsson, R., & Andersson, C. R. (2023) · BMC Cancer · doi:10.1186/s12885-023-10645-4 · Cited by 21
Few-Shot Drug Synergy Prediction With a Prior-Guided Hypernetwork Architecture
Zhang, Q., Zhang, S., Feng, Y.-H., & Shi, J. (2023) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.2023.3248041 · Cited by 21
lncHUB2: aggregated and inferred knowledge about human and mouse lncRNAs
Marino, G. B., Wojciechowicz, M. L., Clarke, D. J. B., Kuleshov, M. V., Xie, Z., Jeon, M., Lachmann, A., & Ma’ayan, A. (2023) · Database · doi:10.1093/database/baad009 · Cited by 22
Yang, D., Huang, F., Wei, W., Li, Q., Wu, J., Huang, Y., Li, Z., Zhang, H., Li, X., Yuan, Q.-E., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.79654 · Cited by 21
Masson, S. W. C., Madsen, S., Cooke, K. C., Potter, M., Díaz‐Vegas, A., Carroll, L., Thillainadesan, S., Cutler, H. B., Walder, K. R., Cooney, G. J., et al. (2023) · eLife · doi:10.7554/elife.86961 · Cited by 24
Wang, X., Yang, L., Yu, C., Ling, X., Guo, C., Chen, R., Li, D., & Liu, Z. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107230 · Cited by 21
Self-citationMacaya, I., Román, M., Welch, C., Entrialgo‐Cadierno, R., Salmón, M., Santos, A., Feliu, I., Kovalski, J. R., López, I., Rodríguez‐Remírez, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41828-z · Cited by 22
Meiners, F., Hinz, B., Boeckmann, L., Secci, R., Sueto, S. O. B., Kuepfer, L., Fuellen, G., & Barrantes, I. (2024) · Scientific Reports · doi:10.1038/s41598-024-55870-4 · Cited by 22
Using network pharmacology to discover potential drugs for hypertrophic scars
Zhang, Y., Li, X., Yu, Q., Lv, X., Li, C., Wang, L., Liu, Y., Wang, Q., Yang, Z., Fu, X., et al. (2024) · British Journal of Dermatology · doi:10.1093/bjd/ljae234 · Cited by 21
Scoring functions for drug-effect similarity
Struckmann, S., Ernst, M., Fischer, S., Mah, N., Fuellen, G., & Möller, S. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa072 · Cited by 21
Klein, J., Caubet, C., Camus, M., Makridakis, M., Denis, C., Gilet, M., Feuillet, G., Rascalou, S., Neau, E., Garrigues, L., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-71950-7 · Cited by 21
Xu, D., Zhang, J., Xu, H., Zhang, Y., Chen, W., Gao, R., & Dehmer, M. (2020) · BMC Genomics · doi:10.1186/s12864-020-07038-3 · Cited by 23
Kim, E. S., Kida, K., Mok, J., Seong, Y., Jo, S. Y., Kanaki, T., Horikawa, M., Kim, K., Kim, T. M., Park, T. S., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120742 · Cited by 21
Pérez-Moraga, R., Forés-Martos, J., Suay‐García, B., Duval, J. L., Falcó, A., & Climent, J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040488 · Cited by 21
Lee, S., Jung, J., Lee, Y., Kim, S., Kim, J., Kim, B., Park, K. C., Kwon, B., & Han, D. C. (2021) · Cancers · doi:10.3390/cancers13122987 · Cited by 21
Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence.Preprint
Hsieh, K., Wang, Y., Chen, L., Zhao, Z., Savitz, S. I., Jiang, X., Tang, J. P., & Kim, Y. (2022) · PubMed · Cited by 21
Rodríguez‐Blanco, J., Salvador, A., Suter, R. K., Swiderska‐Syn, M., Palomo-Caturla, I., Kliebe, V. M., Shahani, P. H., Peterson, K. D., Turos‐Cabal, M., Vieira, M. E., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci171136 · Cited by 21
Hu, G.-S., Zheng, Z., He, Y., Wang, D.-C., Nie, R.-C., & Liu, W. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.100919 · Cited by 22
Artificial intelligence and anti-cancer drugs' response
Long, X., Sun, K., Lai, S., Liu, Y., Su, J., Chen, W., Liu, R., He, X., Zhao, S., & Huang, K. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.05.009 · Cited by 21
Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures
Satpathy, S., Clark, N. M., Chen, Y., Hosseini, N., Chang, Y.-H., Hsiao, Y., Lei, J. T., Petralia, F., Chen, J., Geffen, Y., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.07.011 · Cited by 23
Precision cardiovascular medicine: shifting the innovation paradigm
Aikawa, M., Sonawane, A. R., Chelvanambi, S., Asano, T., Halu, A., Matamalas, J. T., Singh, S. A., Uchida, S., Aïkawa, E., Arenas, À., et al. (2025) · Frontiers in Science · doi:10.3389/fsci.2025.1474469 · Cited by 24
Gonçalves, I., Pan, M., Singh, P., Wang, W., Zhao, J., Dib, L. H., Sundius, L., Persson, A. F., Gialeli, C., Fountas, P., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf1091 · Cited by 22
Evaluating the consistency of large-scale pharmacogenomic studies
Rahman, R., Dhruba, S. R., Matlock, K., Niz, C. D., Ghosh, S., & Pal, R. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby046 · Cited by 18
L1000 Viewer: A Search Engine and Web Interface for the LINCS Data Repository
Musa, A., Tripathi, S., Dehmer, M., & Emmert‐Streib, F. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00557 · Cited by 19
A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients’ Omics Signatures
Mokou, M., Lygirou, V., Angelioudaki, I., Paschalidis, N., Stroggilos, R., Frantzi, M., Latosińska, A., Bamias, A., Hoffmann, M. J., Mischak, H., et al. (2020) · Cancers · doi:10.3390/cancers12123519 · Cited by 20
Meijboom, K. E., Volpato, V., Monzón‐Sandoval, J., Hoolachan, J. M., Hammond, S. M., Abendroth, F., de Jong, O. G., Hazell, G., Ahlskog, N., Wood, M. J. A., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.149446 · Cited by 20
The Trifecta of Single-Cell, Systems-Biology, and Machine-Learning Approaches
Weisskittel, T., Correia, C., Yu, G., Ung, C. Y., Kaufmann, S. H., Billadeau, D. D., & Li, H. (2021) · Genes · doi:10.3390/genes12071098 · Cited by 20
Haider, M., Dholakia, D., Panwar, A., Garg, P., Gheware, A., Singh, D., Singhal, K., Burse, S. A., Kumari, S., Sharma, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99444-0 · Cited by 20
McNulty, M. T., Fermin, D., Eichinger, F. H., Jang, D., Kretzler, M., Burtt, N. P., Pollak, M. R., Flannick, J. A., Weins, A., Friedman, D. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.10.041 · Cited by 20
A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease
Timmons, J. A., Anighoro, A., Brogan, R. J., Stahl, J., Wahlestedt, C., Farquhar, D. G., Taylor‐King, J. P., Volmar, C., Kraus, W. E., & Phillips, S. M. (2021) · eLife · doi:10.7554/elife.68832 · Cited by 21
Wu, A. T. H., Lawal, B., Tzeng, Y., Shih, C.-C., & Shih, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031281 · Cited by 20
Fast and accurate gene regulatory network inference by normalized least squares regression
Hillerton, T., Seçi̇lmi̇ş, D., Nelander, S., & Sonnhammer, E. L. L. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac103 · Cited by 19
Bi, Y., Wu, Z., & Cao, F. (2022) · BMC Cancer · doi:10.1186/s12885-022-09328-3 · Cited by 20
Zhao, K., Shi, Y., & So, H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020234 · Cited by 20
Thaiparambil, J. T., Dong, J., Grimm, S. L., Perera, D. N., Ambati, C. S. R., Putluri, V., Robertson, M. J., Patel, T. D., Mistretta, B., Gunaratne, P. H., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.4933 · Cited by 19
Xu, T., Wang, Z., Liu, J., Wang, G., Zhou, D., Du, Y., Li, X., Xia, Y., & Gao, Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.820696 · Cited by 21
Identifying Candidate Flavonoids for Non-Alcoholic Fatty Liver Disease by Network-Based Strategy
Lee, W.-Y., Lee, C.-Y., Lee, J.-S., & Kim, C.-E. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.892559 · Cited by 21
Hope, K. A., Berman, A. R., Peterson, R. T., & Chow, C. Y. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010228 · Cited by 20
Industrializing AI-powered drug discovery: lessons learned from the Patrimony computing platform
Guedj, M., Swindle, J., Hamon, A., Hubert, S., Desvaux, E., Laplume, J., Xuereb, L., Lefèbvre, C., Haudry, Y., Gabarroca, C., et al. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2095368 · Cited by 23
DeLTa-Seq: direct-lysate targeted RNA-Seq from crude tissue lysate
Kashima, M., Kamitani, M., Nomura, Y., Mori-Moriyama, N., Betsuyaku, S., Hirata, H., & Nagano, A. J. (2022) · Plant Methods · doi:10.1186/s13007-022-00930-x · Cited by 18
van Leeuwen, J. E., Ba-Alawi, W., Branchard, E., Cruickshank, J., Schormann, W., Longo, J., Silvester, J., Gross, P. L., Andrews, D. W., Cescon, D. W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33144-9 · Cited by 20
Zhang, C., Zeng, C., Xiong, S., Zhao, Z., & Wu, G. (2022) · Scientific Reports · doi:10.1038/s41598-022-23463-8 · Cited by 21
Improved drug response prediction by drug target data integration via network-based profiling
Pak, M., Lee, S., Sung, I., Koo, B., & Kim, S. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad034 · Cited by 21
TIP60 is required for tumorigenesis in non‐small cell lung cancer
Shibahara, D., Akanuma, N., Kobayashi, I. S., Heo, E., Ando, M., Fujii, M., Jiang, F., Prin, P. N., Pan, G., Wong, K., et al. (2023) · Cancer Science · doi:10.1111/cas.15785 · Cited by 19
Wu, L., Zhou, L., An, J., Shao, X., Zhang, H., Wang, C., Zhao, G., Chen, S., Cui, X., Zhang, X., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04228-x · Cited by 20
Gene panel selection for targeted spatial transcriptomics
Zhang, Y., Petukhov, V., Biederstedt, E., Que, R. A., Zhang, K., & Kharchenko, P. V. (2024) · Genome biology · doi:10.1186/s13059-024-03174-1 · Cited by 22
Jeong, S., Park, B., Kim, J., Lee, S., You, H., Lee, J. H., Lee, S. O., Park, J.-H., Kim, J., Sim, W., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02410-x · Cited by 22
Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancer
Wang, Y., Pattarayan, D., Huang, H., Zhao, Y., Li, S., Wang, Y., Zhang, M., Li, S., & Yang, D. (2024) · Nature Communications · doi:10.1038/s41467-024-47433-y · Cited by 20
In silico drug discovery: a machine learning-driven systematic review
Atasever, S. (2024) · Medicinal Chemistry Research · doi:10.1007/s00044-024-03260-w · Cited by 29
A network-based trans-omics approach for predicting synergistic drug combinations
Iida, M., Kuniki, Y., Yagi, K., Goda, M., Namba, S., Takeshita, J., Sawada, R., Iwata, M., Zamami, Y., Ishizawa, K., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00571-2 · Cited by 19
Metabolic mapping of the human solute carrier superfamily
Wiedmer, T., Teoh, S. T., Christodoulaki, E., Wolf, G., Tian, C., Sedlyarov, V., Jarret, A. P., Leippe, P., Frommelt, F., Inglés‐Prieto, Á., et al. (2025) · Molecular Systems Biology · doi:10.1038/s44320-025-00106-4 · Cited by 21
de Anda‐Jáuregui, G., Guo, K., & Hur, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020386 · Cited by 20
Jiang, P., Scarpa, J. R., Gao, V., Vitaterna, M. H., Kasarskis, A., & Turek, F. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-41248-4 · Cited by 20
Lu, G., Chen, L., Wu, S., Feng, Y., & Lin, T. (2020) · Disease Markers · doi:10.1155/2020/8974793 · Cited by 20
IBD Systems Biology Is Here to Stay
Fiocchi, C., & Iliopoulos, D. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa343 · Cited by 21
Huang, L., Yi, X., Yu, X., Wang, Y., Zhang, C., Qin, L., Guo, D., Zhou, S., Zhang, G., Deng, Y., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.762023 · Cited by 19
Xiao, Z., Jin-yin, L., Yu, Q., Zhou, T., Duan, J., Yang, Z., Liu, C., & Xu, F. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.778294 · Cited by 20
Drug repurposing through joint learning on knowledge graphs and literaturePreprint
Alshahrani, M., & Hoehndorf, R. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/385617 · Cited by 19
Tuddenham, J. F., Taga, M. F., Haage, V. C., Roostaei, T., White, C. C., Lee, A., Fujita, M., Khairallah, A., Green, G., Hyman, B. T., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.04.494709 · Cited by 20
Yaung, K. N., Yeo, J. G., Kumar, P., Wasser, M., Chew, M., Ravelli, A., Law, A. H. N., Arkachaisri, T., Martini, A., Pisetsky, D. S., et al. (2023) · The Lancet Rheumatology · doi:10.1016/s2665-9913(23)00010-3 · Cited by 22
Dilger, M., Armant, O., Ramme, L., Mülhopt, S., Sapcariu, S. C., Schlager, C., Dilger, E., Reda, A., Orasche, J., Schnelle‐Kreis, J., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.108169 · Cited by 20
Ni, S., Kong, X., Zhang, Y., Chen, Z., Wang, Z., Fu, Z., Huo, R., Tong, X., Qu, N., Wu, X., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100655 · Cited by 19
Self-citationDeng, H., Rukhlenko, O. S., Joshi, D., Hu, X., Junk, P., Tuliakova, A., Kholodenko, B. Ν., & Schwartz, M. A. (2025) · Science Advances · doi:10.1126/sciadv.ado9970 · Cited by 21
Park, K., & Jeon, M. (2025) · Pharmaceuticals · doi:10.3390/ph18121793 · Cited by 20
Lin, C.-F., Hsu, K., HuangFu, W., Lin, T. E., Huang, H.-L., & Pan, S. (2020) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-020-0400-0 · Cited by 19
Hu, W., Wang, G., Chen, Y., Yarmus, L. B., Liu, B., & Wan, Y. (2020) · Aging · doi:10.18632/aging.103775 · Cited by 19
Tabari, M. A. K., Khoshhal, H., Tafazoli, A., Khandan, M., & Bagheri, A. (2020) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2020.100458 · Cited by 19
Scarpa, J. R., DiNatale, R. G., Mano, R., Silagy, A. W., Kuo, F., Irie, T., McCormick, P. J., Fischer, G. W., Hakimi, A. A., & Mincer, J. S. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1852 · Cited by 19
Rao, D. B., Panneerpandian, P., Balakrishnan, K., & Ganesan, K. (2021) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-021-00608-4 · Cited by 19
International Prognostic Index-Based Immune Prognostic Model for Diffuse Large B-Cell Lymphoma
Mu, S., Shi, D., Ai, L., Fan, F., Peng, F., Sun, C., & Hu, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.732006 · Cited by 19
Interrogating mechanisms of liver fibrosis with omics
Oakley, F. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00567-6 · Cited by 19
Li, Z., Zou, L., Xiao, Z. J., & Yang, J. (2022) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2022.5131 · Cited by 19
Repurposing Histaminergic Drugs in Multiple Sclerosis
Amadio, S., Conte, F., Esposito, G., Fiscon, G., Paci, P., & Volonté, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116347 · Cited by 19
Pavel, A., Saarimäki, L. A., Möbus, L., Federico, A., Serra, A., & Greco, D. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.08.061 · Cited by 19
Navigating Transcriptomic Connectivity Mapping Workflows to Link Chemicals with Bioactivities
Shah, I., Bundy, J., Chambers, B., Everett, L. J., Haggard, D., Harrill, J., Judson, R. S., Nyffeler, J., & Patlewicz, G. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00245 · Cited by 19
Deng, J., Leijten, E. F. A., Nordkamp, M. A. M. O., Zheng, G., Pouw, J. N., Tao, W., Hartgring, S. A. Y., Balak, D., Rijken, R., Huang, R., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.976 · Cited by 19
Recent development of machine learning models for the prediction of drug-drug interactions
Hong, E., Jeon, J., & Kim, H. U. (2023) · Korean Journal of Chemical Engineering · doi:10.1007/s11814-023-1377-3 · Cited by 19
Novakovsky, G., Sasaki, S., Fornés, O., Omur, M. E., Huang, H., Bayly, C. L., Zhang, D., Lim, N., Cherkasov, A. R., Pavlidis, P., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.01.008 · Cited by 21
Patrick, M. T., Nair, R. P., He, K., Stuart, P. E., Billi, A. C., Zhou, X., Gudjonsson, J. E., Oksenberg, J. R., Elder, J. T., & Tsoi, L. C. (2023) · Annals of Neurology · doi:10.1002/ana.26672 · Cited by 20
Małachowska, B., Yang, W., Qualman, A. C., Muro, I., Boe, D. M., Lampe, J. N., Kovacs, E. J., & Idrovo, J. (2023) · Communications Biology · doi:10.1038/s42003-023-04964-2 · Cited by 19
Pravalphruekul, N., Piriyajitakonkij, M., Phunchongharn, P., & Piyayotai, S. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00355 · Cited by 21
De novo drug design based on patient gene expression profiles via deep learning
Yamanaka, C., Uki, S., Kaitoh, K., Iwata, M., & Yamanishi, Y. (2023) · Molecular Informatics · doi:10.1002/minf.202300064 · Cited by 22
Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood
Bourdakou, M. M., Fernández-Ginés, R., Cuadrado, A., & Spyrou, G. M. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102881 · Cited by 20
An overview of recent advances and challenges in predicting compound-protein interaction (CPI)
Li, Y., Fan, Z., Rao, J., Chen, Z., Chu, Q., Zheng, M., & Li, X. (2023) · Medical Review · doi:10.1515/mr-2023-0030 · Cited by 19
Qian, Z.-Y., Pan, Y., Li, X., Chen, Y., Wu, H., Liu, Z., Košař, M., Bártek, J., Wang, Z., & Xu, R. (2024) · 中国科学通报：英文版 · doi:10.1016/j.scib.2024.01.025 · Cited by 19
Self-citationKim, J.-B., Kim, S., So, M., Kim, D., Noh, H. R., Kim, B. J., Choi, Y. R., Kim, D., Koo, H., Kim, T. Y., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116442 · Cited by 19
Recent Advances in and Application of Fluorescent Microspheres for Multiple Nucleic Acid Detection
Chen, Z., Luo, G., Ren, J., Wang, Q., Zhao, X. C., Wei, L., Wang, Y., Liu, Y., Deng, Y., & Li, S. (2024) · Biosensors · doi:10.3390/bios14060265 · Cited by 19
Turning omics data into therapeutic insights
Kedaigle, A. J., & Fraenkel, E. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.08.006 · Cited by 20
Recent advances in target identification of bioactive natural products
Yoshida, M. (2018) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2018.1533804 · Cited by 19
Metadata
- Authors
- Subramanian, A., Narayan, R., Corsello, S. M., Peck, D. D., Natoli, T. E., Lu, X., Gould, J., Davis, J. F., Tubelli, A. A., Asiedu, J. K., Lahr, D. L., Hirschman, J. E., Liu, Z., Donahue, M., Julian, B., Khan, M., Wadden, D., Smith, I. C., Lam, D., Liberzon, A., Toder, C., Bagul, M., Orzechowski, M., Enache, O. M., Piccioni, F., Johnson, S. A., Lyons, N. J., Berger, A. H., Shamji, A. F., Brooks, A. N., Vrcic, A., Flynn, C., Rosains, J., Takeda, D. Y., Hu, R., Davison, D., Lamb, J., Ardlie, K., Hogstrom, L., Greenside, P., Gray, N. S., Clemons, P. A., Silver, S., Wu, X., Zhao, W.-N., Read-Button, W., Wu, X., Haggarty, S. J., Ronco, L. V., Boehm, J. S., Schreiber, S. L., Doench, J. G., Bittker, J. A., Root, D. E., Wong, B., & Golub, T. R.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Golub, Todd R.
- ORCID
- Subramanian, Aravind
- Corsello, Steven M.
- Gould, Joshua
- Tubelli, Andrew A.
- Lahr, David L.
- Hirschman, Jodi E.
- Liu, Zihan
- Khan, Mariya
- Smith, Ian C.
- Orzechowski, Marek
- Enache, Oana M.
- Piccioni, Federica
- Johnson, Sarah A.
- Berger, Alice H.
- Brooks, Angela N.
- Vrcic, Anita
- Takeda, David Y.
- Ardlie, Kristin
- Gray, Nathanael S.
- Clemons, Paul A.
- Silver, Serena
- Wu, Xiaoyun
- Zhao, Wen-Ning
- Haggarty, Stephen J.
- Ronco, Lucienne V.
- Boehm, Jesse S.
- Schreiber, Stuart L.
- Doench, John G.
- Bittker, Joshua A.
- Root, David E.
- Golub, Todd R.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 171
- Issue
- 6
- Pages
- 1437-1452.e17
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC5990023
- OpenAlex
- W2612467560
- Cited by
- 3,515
- References
- 73
- Citations by year
- 2026: 436 · 2025: 479 · 2024: 493 · 2023: 458 · 2022: 507 · 2021: 421 · 2020: 320 · 2019: 261 · 2018: 122 · 2017: 12
- FWCI
- 80.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- NIH (U54HG006093, U54HL127366, U01HG008699, CA009172, TR001100)
- Conquer Cancer Foundation of ASCO Young
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- Connectivity Map, L1000, gene expression signatures, functional annotation of genetic variants, reproducibility, clinical trial design
- MeSH terms
- Pharmaceutical Preparations, Humans, Neoplasms, Organ Specificity, Sequence Analysis, RNA, Drug Resistance, Neoplasm, Gene Expression Profiling, Cell Line, Tumor, Small Molecule Libraries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
